Jameson, A, Fylan, B, Bristow, G et al. (5 more authors) (2022) Pharmacogenomics is the future of prescribing in psychiatry. Pharmaceutical Journal, 309. 7964. ISSN 2053-6186
Abstract
Patients' pharmacogenetic data could be used to improve adherence to antipsychotic medication by increasing the likelihood of therapeutic response and reducing the prevalence of adverse drug reactions.
Metadata
| Item Type: | Article |
|---|---|
| Authors/Creators: |
|
| Copyright, Publisher and Additional Information: | This is protected by copyright. All rights reserved. This is an author produced version of an article published in Pharmaceutical Journal. Uploaded in accordance with the publisher's self-archiving policy. |
| Dates: |
|
| Institution: | The University of Leeds |
| Academic Units: | The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Health Sciences (Leeds) > Academic Unit of Psychiatry and Behavioural Sciences (Leeds) |
| Depositing User: | Symplectic Publications |
| Date Deposited: | 27 Oct 2022 13:07 |
| Last Modified: | 27 Oct 2022 13:07 |
| Status: | Published |
| Publisher: | Royal Pharmaceutical Society |
| Identification Number: | 10.1211/pj.2022.1.152215 |
| Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:192139 |

CORE (COnnecting REpositories)
CORE (COnnecting REpositories)